Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL31546359 | 0.97 | MEN1 (0.54) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL31546440 | 0.92 | MEN1 (0.55) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL30584854 | 0.91 | MAPT (0.47) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL25437981 | 0.89 | LMNA (0.59) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL30584763 | 0.89 | MAPT (0.45) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL30584894 | 0.89 | MEN1 (0.55) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL31667383 | 0.89 | MEN1 (0.57) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL31667355 | 0.88 | LMNA (0.58) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL30584734 | 0.87 | MAPT (0.58) | MEN1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL31546403 | 0.87 | MEN1 (0.56) | MEN1KMT2AMAPTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4463452-B1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC (US) | 2025-07-30 | — | — | EP | claimed |
| EP-4463452-B1 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC (US) | 2025-07-30 | — | — | EP | disclosed |